Heart pill trial aims to ease burden for new dialysis patients
NCT ID NCT05498181
Summary
This study is testing if a medication called sacubitril/valsartan, typically used for heart failure, can help people who are just starting dialysis. Researchers want to see if the drug helps control fluid buildup, protects any remaining kidney function, and is safe for this group. About 100 new dialysis patients will receive either the real drug or a placebo pill for 16 weeks to compare results.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Brigham and Women's
RECRUITINGBoston, Massachusetts, 02115, United States
Contact
Contact
Conditions
Explore the condition pages connected to this study.